The Tooth Collar Technique
TCTechnique
1 other identifier
interventional
30
1 country
4
Brief Summary
The aim of this study is to evaluate wound healing after the application of the Tooth Collar Technique (TCT) for bone augmentation in the upper or lower jaw. This technique is designed to promote tension-free wound closure and to reduce the risk of wound dehiscence. Augmentation is performed under local anesthesia. The gingiva is opened according to the TCT, after which the bone defect is reconstructed with standard biomaterials and covered with a membrane. No experimental materials are used- only a modified incision technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2026
CompletedFirst Posted
Study publicly available on registry
August 7, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
Study Completion
Last participant's last visit for all outcomes
August 1, 2028
August 7, 2026
March 1, 2026
1.5 years
March 2, 2026
August 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
early wound dehiscence
Incidence of early wound dehiscence (yes/no) at the crest of the surgical site
within 14 days after augmentation
Early Wound dehiscence
Documentation of location of wound dehiscence (if there is wound dehiscence) with clinical photo
within 14 days after augmentation
primary wound healing
quality of primary wound healing using Wound Healing Index (WHI) of PMID16253095 ( score 1 = uneventful healing with nogingival edema, erythema, suppuration, patient dis-comfort, or flap dehiscence; score 2 = uneventfulhealing with slight gingival edema, erythema, patientdiscomfort, or flap dehiscence, but no suppuration;and score 3 = poor wound healing with significantgingival edema, erythema, patient discomfort, flapdehiscence, or any suppuration.)
within 14 days after augmentation
Early Wound dehiscence
Measurement of maximal defect dimension ( in case of wound dehiscence; with periodontal probe; in mm)
within 14 days after augmentation
Secondary Outcomes (7)
soft tissue healing quality
day 7, 14, 30 and 120 after augmentation
Need for -re-intervantions
within 30 days after augmentation
incidence of post-operative infection
within 30 days after augmentation
Gingival condition
at 4 months after augmentation
Procedural parameters: closure tension
immediately after surgery
- +2 more secondary outcomes
Study Arms (1)
Tooth Collar Technique
EXPERIMENTALParticipants of the study will receive surgery using the Tooth Collar Technique prior to ridge augmentation.
Interventions
During surgery, the gingiva will be opened using tooth collar technique instead of standard flap designs; after which the bone defect is augmented using standard biomaterials and covered with a membrane.
Eligibility Criteria
You may qualify if:
- Voluntary written informed consent of the participant or their legal authorized representative has been obtained prior to any screening procedures
- At least 18 years of age at the time of signing the Informed Consent Form (ICF)
- Indication for horizontal and/or vertical bone augmentation in the maxilla or mandible in preparation for implant placement
- Sufficient general health to undergo elective oral surgical procedures, as judgjed by the investigator
- Ability and willingness to attend all study visits and comply with the protocol requirements.
You may not qualify if:
- Current smoking or use of other nicotine-containing products (eg, e-cigarettes, chewing tobacco)
- Presence of uncontrolled systemic diseases that may compromise healing
- Ongoing chemotherapy, radiotherapy, or bisposphonate/anti-resorptive therapy in the head or neck region
- History of radiation therapy to the jaws
- active or untreated periodontal disease, caries or poor oral hygiene
- Poorly fitting restorations on teeth adjacent to the augmentation site
- Known allergy or hypersensitivity to any material used in the augmentation procedure.
- Pregnant or breastfeeding women, or women planning pregnancy during the study period.
- Participation in another interventional clinical study within the last 30 days
- Any other condition or circumstance that, in the opinion of the investigator, could compromise participant safety, compliance, or the validity of the study results.
- Participation in an interventional study with an investigational medicinal product or device.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitaire Ziekenhuizen KU Leuvenlead
- Paro Plus Aalst (https://paroplus.be/; private practice contracted by UZ Leuven)collaborator
- Radix (https://radix-dental.be/); Privcate practice contracted by UZ Leuven)collaborator
- Paro Merchtem (https://paromerchtem.be/; private practice contracted by UZ Leuven)collaborator
Study Sites (4)
ParoPlus Aalst
Aalst, Oost-Vlaanderen, 9300, Belgium
Radix Dental
Heist-op-den-Berg, Vlaams Brabant, 2220, Belgium
Parodontologie & Implantologie Merchtem
Merchtem, Vlaams Brabant, 1785, Belgium
UZ Leuven
Leuven, 3000, Belgium
Study Officials
- PRINCIPAL INVESTIGATOR
Ana B Castro, Professor
UZLeuven, department of Oral Health Sciences, Periodontology
- PRINCIPAL INVESTIGATOR
Andy Temmerman, Professor
ParoPlus Aalst
- PRINCIPAL INVESTIGATOR
Lorenz Seyssens, Dr
ParoPlus Aalst
- PRINCIPAL INVESTIGATOR
Rutger Dhondt, Dr.
Radix Dental
- PRINCIPAL INVESTIGATOR
Alexander De Greef, Drs
Parodontologie & Implantologie Merchtem
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2026
First Posted
August 7, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
August 1, 2028
Last Updated
August 7, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share